Home / Education / Education Courses / Psychopharmacology 2021

Psychopharmacology 2021

Event Date(s): Oct 21, 2021 - 04:00pm to Oct 24, 2021 - 05:00pm

This psychiatry conference examines the latest research and treatment advances across dozens of mental health conditions. It offers in-depth information that is important for all mental health and primary care settings. Topics include ADHD, anxiety, bipolar disorder, depression, OCD, psychosis, PTSD, substance use disorders, and much more.

Available Credits: 30.50 AMA PRA Category 1 Credit™ 30.50 Nursing Contact Hours 30.50 Social Workers 30.50 Participation 30.50 Psychologists CE Credit Register For This Course

Course Details

Now Virtual! 


Engage the experts. Get your questions answered.

This psychiatry conference examines the latest research and treatment advances across dozens of mental health conditions. It offers in-depth information that is important for all mental health and primary care settings. Topics include ADHD, anxiety, bipolar disorder, depression, OCD, psychosis, PTSD, substance use disorders, and much more.

In every session, our faculty share any data from new clinical trials. They match it up against prior data and discuss what the changes mean. They also examine standards of care and share innovative ways to make care better. The agenda touches on many complex topics in mental health. Managing side effects, drug interactions, natural medications, combining pharmacologic and psychosocial treatments, and much more.

Most important of all, our faculty focus on how to translate all these insights into your daily practice. This empowers you to optimize your care for patients with psychiatric conditions. That makes our event ideal for professionals in psychiatry, primary care, psychology, and nursing.
 


NOTE:

If you purchased the bundled admission to Women's Mental Health and Psychopharmacology 2021 you must complete the evaluations for both events in order to claim all credit. The Women’s Mental Health course has been pre-loaded into your account. You may access the evaluation and your certificate for that conference at the link below:

lms.mghcme.org/wmhlive2021

 


Pricing

3-DAY PSYCHOPHARMACOLOGY CONFERENCE

MDs/Doctoral-Level Professionals
Super Early Bird Registration (on or before July 28, 2021): $549.00
Early Bird Registration (on or before September 4, 2021): $649.00
Regular Registration (after September 4, 2021): $699.00 

Other Professionals or Trainees
Super Early Bird Registration (on or before July 28, 2021): $309.00
Early Bird Registration (on or before September 4, 2021): $409.00 
Regular Registration (after September 4, 2021): $459.00

THURSDAY SESSIONS
October 21, 2021

Clozapine Workshop: $175

Women’s Mental Health: $250 
If you are interested in attending the Women's Mental Health session ONLY, you can register for it by clicking here
This is a full day program that precedes the Psychopharmacology program and offers an additional 6.25 of CME/CEU credits.

Thursday Evening Sessions: $175
Choose between the following topics:

  • Law and Psychiatry
  • Psychosomatic Medicine/Consultation-Liaison Psychiatry
  • The Neuroscience Revolution: How will it Affect Patient Care?


PSYCHOPHARMACOLOGY AND WOMEN’S MENTAL HEALTH BUNDLED PRICING (SAVINGS OF $55)

MDs/Doctoral-Level Professionals
Super Early Bird Registration (on or before August 4, 2021) = $744
Early Bird Registration (on or before September 4, 2021) = $849
Regular Registration (after September 4, 2021) = $899

Other Professionals or Trainees 
Super Early Bird Registration (on or before August 4, 2021) = $504
Early Bird Registration (on or before September 4, 2021) = $609
Regular Registration (after September 4, 2021) = $659

 


Syllabus

Price: $48.00
Shipping: $25.00
Total: $73.00

Available for purchase on or before September 24, 2021

The conference syllabus is a printed book with all slide presentations and space to take notes adjacent to each slide. As an alternative to purchasing a conference syllabus, we provide all attendees with completely free access to all slide presentations in digital PDF format prior to the conference. This is an environmentally friendly alternative and helps keep costs lower for all attendees.
 


Cancellation Policy

A refund minus a $100.00 administrative fee will be issued for refund requests received by October 1, 2021.  No refunds will be issued for refund requests made after October 1, 2021. Payments made may not be applied to future conferences or other educational activities. There are no exceptions to these policies.

Course Summary

Available Credits:30.50 AMA PRA Category 1 Credit™ 30.50 Nursing Contact Hours 30.50 Social Workers 30.50 Participation 30.50 Psychologists CE Credit
Course Topic:Conference, Psychopharmacology
Course Format:Conference / meeting
Target Audience:

This program is intended for:

Psychiatrists
Psychologists
General and Family Practice Physicians
Psychiatric Nurses
Physician Assistants
Nurse Practitioners
Social Workers

Event Starts: Oct 21, 2021 - 04:00pm
Event Ends: Oct 24, 2021 - 05:00pm
Cost: $699.00

Learning Objectives

Our conference lets you engage dozens of renowned clinician-researchers, get your clinical questions answered, and translate enhanced knowledge into optimal patient care.

Here are some of the ways that participants plan to change their clinical practice as a result of attending our conference:

  • Identify rational, evidence-based pharmacologic and non-pharmacologic therapies for patients with unipolar, bipolar, treatment-resistant, and post-partum depression.
  • Assess obstacles to maintenance of long-term recovery and the liability issues associated with psychopharmacology.
  • Discuss diagnostic and evidenced-based treatment strategies for pediatric onset mood disorders.
  • Compare the neurobiology and evidence-based treatment approaches to addiction, anxiety, schizophrenia, and mood disorders.
  • Review the course and treatment of psychiatric disorders during pregnancy and menopause.
  • Recognize psychosocial issues and evidence-based treatment modalities for eating and sleep disorders.
  • Analyze drug interactions and the pharmacotherapy of adult ADHD and geriatric disorders.
  • Focus on reducing side effects of medication
  • Apply newer strategies in treatment of chemical abuse/dependence
  • Explain more succinctly why to choose a particular medication for a person
  • Explain more clearly how medications affect behaviors and mood
  • Use more evidence-based treatment for psychiatric illness
  • Move to augmentation strategies sooner
  • Screen patients for presence of substance use disorders, especially nicotine and alcohol
  • Renew a collaborative relationship with specialists to begin assisting in performing medication renewals
  • Include newly researched alternatives for augmentation treatment in refractory patients
  • More confidently weigh risks and benefits of treating vs. not continuing treatment during pregnancy
  • Be more cautious associating medications
  • Improve ability to convey to patients the range of treatment options
  • Better evaluate whether medication is needed and consider alternative treatments
  • Institute adjunctive medications that were not thought of previously
  • Follow new algorithms for treatment of bipolar disorder, major depression and schizophrenia
  • Integrate more augmentation strategies and increase use of maintenance ECT
  • Inform patients and colleagues of the most recent state-of-the-art alternatives
  • Take a more substantial sleep history
  • Consider problems that are causing difficulties with cognition, mood, and anxiety
  • Try natural remedies for treatment of depression
  • Educate patients more thoroughly with recent study results
  • Provide patients with more focused and comprehensive discussions regarding and symptom complexes
  • Be more knowledgeable and complete when referring patients
  • Develop a plan to use CBT based techniques
  • Change approaches related to maintenance treatment of bipolar disorder and treatment of mood disorders during pregnancy
  • Thoroughly discuss with patients how current available treatments work and increase medication adherence

Clozapine Workshop Objectives

  • Identify patients for a clozapine trial
  • Prepare treatment with clozapine
  • Assess patient on clozapine maintenance treatment

Neuroscience Evening Seminar Objectives

  • To distinguish genetic tests that are currently useful in clinical practice from those that may be useful in the future
  • To describe neurotherapeutic techniques that are currently useful and those that may be on the near horizon
  • To delineate roles of neuroimaging in clinical practice versus research
  • To describe the utility of electronic health record (EHR) and other "big data" approaches in developing precision medicine interventions

Psychosomatic Evening Seminar Objectives

  • Identify characteristics of seizures and nonepileptic seizures
  • Identify and analyze electrocardiographic characteristics associated with torsades de pointes
  • Identify predisposing factors for delirium and identify effective treatment regimens to prevent and to reduce agitation and confusion.

Law & Psychiatry Evening Seminar Objectives

  • Identify the most common areas of liability for psychiatrists and mental health practitioners and discuss strategies to manage your risk.
  • Discuss the concept of informed consent and exceptions to this requirement in providing psychiatric care, including involuntary treatment.
  • Identify the elements of medical malpractice and describe strategies for mitigating risk of malpractice claims and judgments.
  • Anticipate potential issues in providing psychiatric care to children of divorcing or divorced parents and identify practice points to reduce your risk.